Intensive glycemic management | | |
| No | 0 |
| Yes | 9 |
Baseline age | | |
| 40–49 | 0 |
| 50–59 | 2 |
| 60–69 | 3 |
| 70+ | 5 |
Race | | |
| Other | 0 |
| Black | 4 |
Education | | |
| ≥College | 0 |
| <College | 3 |
Time since diabetes diagnosis (years) | | |
| 0–4.9 | 0 |
| 5–14.9 | 1 |
| 15–19.9 | 2 |
| ≥20 | 4 |
Hypoglycemia within the last week | | |
| No | 0 |
| Yes | 4 |
Current insulin treatment | | |
| No | 0 |
| Yes | 8 |
Current sulfonylurea use | | |
| No | 0 |
| Yes | −4 |
Current biguanide use | | |
| No | 0 |
| Yes | −4 |
Current meglitinide use | | |
| No | 0 |
| Yes | 3 |
Current HMG-CoA reductase inhibitors use | | |
| No | 0 |
| Yes | −2 |
Current antihypertensive use | | |
| No | 0 |
| Yes | 7 |
Systolic blood pressure (mm Hg) | | |
| <130 | 0 |
| 130–139.9 | 2 |
| ≥140 | 3 |
Diastolic blood pressure (mm Hg) | | |
| <70 | 0 |
| 70–79.9 | −2 |
| ≥80 | −4 |
Waist circumference (median) (cm) | | |
| <107 | 0 |
| ≥107 | −2 |
Serum creatinine (median) (mmol/L) | | |
| <0.080 | 0 |
| ≥0.080 | 2 |
Urinary albumin creatinine ratio | | |
| ≤30 | 0 |
| >30 | 1 |